Autolus Therapeutics Earning Date (AUTL)

USA |NASDAQ |USD |ADR

AUTL Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 2, 2022 Dec 2021 $-0.51 - $-0.83
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 2, 2022 Dec 2021 $250.00K - $404.00K

Autolus Therapeutics's next earnings date is Wednesday, Mar 2, 2022 for the fiscal quarter ending Dec 2021.

AUTL Earnings Date & History Chart

AUTL Earnings & Revenue Forecast

AUTL Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 10 $-1.90 $-2.33 $-0.92

AUTL Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-1.92 $-1.92 $-1.92

AUTL Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 10 $760.00K $0.00 $1.77M

AUTL Earnings Date & Revenue History

AUTL Earnings History

|
Show More
Show More

AUTL Revenue History

|
Show More
Show More

Autolus Therapeutics Next Earnings Date & Report

AUTL Next Earnings Date & Report Preview: Dec 2021 (FQ)

AUTL's next earnings date is Wednesday, Mar 2, 2022 for the fiscal quarter ending Dec 31, 2021.

According to analysts, the average EPS estimation for Autolus Therapeutics's next quarterly earnings is $-0.51, with a low EPS estimation of $-0.58, and a high estimation of $-0.44.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.51, the last 2 month trend is $-0.51, and the 3 month trend is $-0.51.

Based on analysts, the average revenue estimation is $250.00K, with a low revenue estimation of $0.00, and a high estimation of $640.00K.

Autolus Therapeutics Previous Earnings Dates & Reports

AUTL Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Autolus Therapeutics's previous earnings date was Nov 3, 2021 for its fiscal quarter ended Sep 30, 2021.

AUTL Previous Earnings Date & Report Recap: Sep 2020 (FY)

Autolus Therapeutics's previous annual earnings date was Nov 5, 2020 for its fiscal year ended Sep 30, 2020.

AUTL's earnings per share (EPS) was $-2.78.

Revenues were $242.00K, down by -91.68% from previous year's revenue.

The company reported a net income of $-142.09M.

Autolus Therapeutics reported a free cash flow of $-132.44M for its fiscal year, compared to $-120.15M a year ago.

The company ended the fiscal year with $54.16M in total debt, an increase of 106.56% compared to the previous year.